ZBH

#610
Zimmer Biomet Holdings, Inc. Common Stock
99.5 1 USD
0.00%
Market Price
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
99.48
100.24
Intervallo Annuale
79.12
103.69
Variazione giornaliera
+0.10%
Variazione Mensile
+4.20%
Variazione di 6 mesi
+1.60%
Variazione Annuale
-3.86%
Chiusura Precedente
99.4 1
Open
100.2 1
Minimo
99.4 8
Massimo
100.2 4
Volume
483
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche Dividendi Documents

2026

Current report, Q3 FY2026
ZIMMER BIOMET HOLDINGS, INC. current report, Q3 FY2026
8-K
Current report, Q3 FY2026
ZIMMER BIOMET HOLDINGS, INC. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
ZIMMER BIOMET HOLDINGS, INC. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
ZIMMER BIOMET HOLDINGS, INC. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
ZIMMER BIOMET HOLDINGS, INC. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
ZIMMER BIOMET HOLDINGS, INC. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
ZIMMER BIOMET HOLDINGS, INC. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
ZIMMER BIOMET HOLDINGS, INC. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
ZIMMER BIOMET HOLDINGS, INC. quarterly report, Q1 FY2026
10-Q
Current report, Q1 FY2026
ZIMMER BIOMET HOLDINGS, INC. current report, Q1 FY2026
8-K

ZIMMER BIOMET HOLDINGS, INC. current report, Q2 FY2015

Full document

Business Context and Reporting Period

This Form 8-K filing by Zimmer Holdings, Inc. (now Zimmer Biomet Holdings, Inc.) reports on the annual meeting of stockholders held on May 5, 2015. The document details the outcomes of five specific proposals submitted to security holders for a vote.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting results rather than financial performance.

Material Changes and Voting Results

Stockholders approved all five proposals presented at the meeting. The vote tabulations are as follows:

  • Proposal 1 (Election of Directors): All 10 nominees were elected. Votes "For" ranged from approximately 129.6 million to 130.4 million, with "Against" votes ranging from 269,733 to 1,018,582.
  • Proposal 2 (Amended Stock Plan for Non-Employee Directors): Approved with 125,988,281 votes "For" and 4,468,057 "Against".
  • Proposal 3 (Amended and Restated Deferred Compensation Plan): Approved with 127,951,466 votes "For" and 2,485,485 "Against".
  • Proposal 4 (Advisory Vote on Executive Compensation): Approved with 125,040,326 votes "For" and 5,164,492 "Against".
  • Proposal 5 (Ratification of Auditor): PricewaterhouseCoopers LLP was ratified with 142,311,960 votes "For" and 1,090,537 "Against".

Guidance, Outlook, and Risks

The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to the reporting of the stockholder vote outcomes.

Investor Verification Checklist

  • Verify the terms of the newly elected directors, specifically their one-year terms ending at the 2016 annual meeting.
  • Review the specific amendments to the Non-Employee Director Stock Plan and Deferred Compensation Plan approved in Proposals 2 and 3.
  • Confirm the engagement of PricewaterhouseCoopers LLP as the independent auditor for the 2015 fiscal year.
  • Note the significant number of broker non-votes (13,206,365) on the director election and other proposals, indicating shares held by brokers that were not voted on those specific items.

Notizie